---
title: 'The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach
  Communities: An Internal Expert Consultation of the VACCELERATE Consortium'
date: '2023-12-23'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38140188/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231224170830&v=2.18.0
source: heidelberg[Affiliation]
description: Underserved and hard-to-reach population groups are under-represented
  in vaccine trials. Thus, we aimed to identify the challenges of vaccine trial participation
  of these groups in member countries of the VACCELERATE network. Seventeen National
  Coordinators (NC), each representing their respective country (15 European countries,
  Israel, and Turkey), completed an online survey. From 15 eligible groups, those
  that were more frequently declared underserved/hard-to-reach in vaccine research
  ...
disable_comments: true
---
Underserved and hard-to-reach population groups are under-represented in vaccine trials. Thus, we aimed to identify the challenges of vaccine trial participation of these groups in member countries of the VACCELERATE network. Seventeen National Coordinators (NC), each representing their respective country (15 European countries, Israel, and Turkey), completed an online survey. From 15 eligible groups, those that were more frequently declared underserved/hard-to-reach in vaccine research ...